The Biotech Rollercoaster Ride: From Lab To Buyout
Caixa Capital Risc's Pablo Cironi On Sanifit's Story
Executive Summary
After investing more than €23m in Sanifit, the Spanish firm being acquired by Vifor Pharma, Caixa Capital's director of life sciences investments spoke to Scrip about the venture capital firm's long-term approach.